Martingale Asset Management’s Puma Biotechnology PBYI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$617K Buy
62,127
+36,763
+145% +$324K 0.02% 626
2026
Q2
$206K Buy
+25,364
New +$186K ﹤0.01% 818
2015
Q1
– Sell
-1,127
Closed -$214K – 892
2014
Q4
$214K Buy
+1,127
New +$250K 0.01% 815

Other funds holding PBYI

Martingale Asset Management's PBYI Position: Q3 2026 in Review

Martingale Asset Management increased its Puma Biotechnology (PBYI) stake by 145% in Q3 2026, buying an estimated $324K and bringing the position to 62,127 shares worth $617K. The position accounts for 0.02% of the portfolio, ranked #626.

Martingale Asset Management first reported a position in PBYI in Q4 2014 and has held it in 3 quarters since. 156 funds tracked by Wall St. Rank hold PBYI as of Q3 2026.

  • Martingale Asset Management held 62,127 shares of Puma Biotechnology worth $617K as of Q3 2026.
  • Martingale Asset Management bought 36,763 Puma Biotechnology shares in Q3 2026, an estimated $324K.
  • Puma Biotechnology made up 0.02% of Martingale Asset Management's portfolio in Q3 2026, its #626 holding.
  • Martingale Asset Management first reported a position in Puma Biotechnology in Q4 2014 and has held it in 3 quarters since.
  • 156 funds tracked by Wall St. Rank held Puma Biotechnology as of Q3 2026.

Based on Martingale Asset Management's 13F filing for Q3 2026, filed 12 Nov 2026.